Fulgent Genetics
FLGT
189 hedge funds and large institutions have $314M invested in Fulgent Genetics in 2024 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 71 increasing their positions, 49 reducing their positions, and 25 closing their positions.
4,613% more call options, than puts
Call options by funds: $43.5M | Put options by funds: $924K
45% more repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 49
24% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 25
3% more funds holding
Funds holding: 183 → 189 (+6)
2.52% more ownership
Funds ownership: 53.11% → 55.63% (+2.5%)
10% less capital invested
Capital invested by funds: $350M → $314M (-$35.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$5.1M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$2.84M |
| 3 |
JP Morgan Chase
New York
|
+$2.6M |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$2.19M |
| 5 |
Jane Street
New York
|
+$2.17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.46M |
| 2 |
AG
Algert Global
San Francisco,
California
|
-$1.77M |
| 3 |
AI
Acuitas Investments
Seattle,
Washington
|
-$1.5M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.49M |
| 5 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$1.4M |
FLGT Hedge Fund Activity: Q4 2024 in Review
189 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q4 2024, worth a combined $314M — down 10% from $350M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new FLGT positions and 25 closed out — a net gain of 6 holders — while 71 added to existing stakes and 49 trimmed.
The largest buyer was Millennium Management, adding an estimated $5.1M. The largest seller was Point72 Asset Management, cutting an estimated $2.46M.
- 189 institutional investors held Fulgent Genetics (FLGT) as of Q4 2024, up from 183 in Q3 2024.
- Funds reported $314M of Fulgent Genetics stock for Q4 2024, down 10% quarter-over-quarter.
- 31 funds opened new Fulgent Genetics positions in Q4 2024 and 25 closed out, a net change of +6 holders.
- The largest Fulgent Genetics buyer in Q4 2024 was Millennium Management, an estimated $5.1M added.
- The largest Fulgent Genetics seller in Q4 2024 was Point72 Asset Management, an estimated $2.46M sold.
Based on aggregated 13F filings for Q4 2024.